Zolmitriptan Tablet, Orally Disintegrating
Product Images NDC 68382-715

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 68382-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 01

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 02

This appears to be a graph depicting the estimated probability of response over time for different doses of three different drugs (zaimitriptan, zoimitriptan, and znipen). The x-axis represents time from the initial dose in hours, while the y-axis represents the probability of response. The placebo is also included for comparison. The highest estimated probability of response is for the highest dose of zoimitriptan (2.5mg), while the lowest response is estimated for the highest dose of znipen (5g).*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 03

This appears to be a chart or graph showing the estimated probability of remedication or rescue over time in hours from an initial dose. However, without additional context it is unclear what substance or treatment the chart is referring to.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 04

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 05

The text seems to be showing data related to the medication "Zamispen 0DT25mg" and its estimated probability of response based on time from initial dose. The graph shows the percentage of response probability over time, starting from 0 up to 18. However, the meaning behind the text is not fully clear and the quality is questionable.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 06

Zolmitriptan Orally Disintegrating Tablets, USP are a prescription drug used to treat migraines. Each tablet contains 2.5 mg of Zolmitriptan, USP. The standard dosage should be determined by a physician. This medication should be kept in a tightly sealed container, protected from light and moisture, at room temperature. These tablets contain Phenylalanine and should not be used by individuals with phenylketonuria. Patients should refer to the package insert for detailed information and consult with their healthcare provider regarding proper use. This medication is manufactured by Cadia HealthCare Ltd and distributed by Zy Pharmaceuticals (USA) Inc.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 07

Orally Disintegrating Zolmitriptan is a medication that can be taken without water since it dissolves quickly in the mouth. It may be useful as a treatment for migraines.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 08

Zolmitriptan is a medication that is usually taken as an orally disintegrating tablet, containing 25mg of Zomitan, USP. The recommended dosage is one tablet per episode. The package should be stored between 20-25°C (68-77°F) and protected from light. The drug should be kept out of reach of children. The medication is distributed by Zydis Pharmaceuticals in the USA, and the manufacturing details are available on the package.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 09

Zolmitriptan is a type of orally disintegrating tablet which contains 5mg of Zomirptan, USP. It is dispensed to patients with a separate set of instructions from pharmacists. Each tablet contains 501mg of Phenylalanine, and the usual dosage is stated in the package insert for complete prescribing information. It must be stored in a cool place, preferably at 68°F to 77°F to remain effective. Cadia Healthcare Ltd. manufactures this tablet, and it is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, in the US. It must be dispensed in a "bright, light-resistant, closed container and kept away from children".*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 10

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 11

This is a description of a medication called Zolmitriptan Orally Disintegrating Tablets, USP. Each tablet contains 5mg of Zolmitriptan and is intended for the treatment of migraines. The recommended dosage is mentioned, along with a warning to individuals with Phenylketonuria as it contains Phenylalanine. Proper storage instructions are also given. The tablet is designed to disintegrate orally. It is emphasized to keep the medication away from the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.